eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | intestinal disease |
| Comorbidity | C0024299|lymphoma |
| Sentences | 14 |
| PubMedID- 22545014 | Patients with concurrent medical or arthritic conditions that could interfere with evaluation of the index knee joint, including fibromyalgia, reiter's syndrome, rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, lymphoma, arthritis associated with inflammatory bowel disease, sarcoidosis, amyloidosis, clinical signs and symptoms of active knee infection, crystal disease, cancer, more significant pain from the back or the hip than the knee, patients with hiv or hcv, and patients with drug or alcohol dependence history or sensitivity to polymerized-type i collagen were also excluded. |
| PubMedID- 21674712 | Primary intestinal lymphoma in patients with inflammatory bowel disease: a descriptive series from the prebiologic therapy era. |
| PubMedID- 25984171 | Revealed a 4-fold increased risk of lymphoma in patients with inflammatory bowel disease, treated with azathioprine [9]. |
| PubMedID- 21830262 | Risk of malignant lymphoma in patients with inflammatory bowel diseases: a dutch nationwide study. |
| PubMedID- 22766526 | The risk of lymphoma and immunomodulators in patients with inflammatory bowel diseases: results from a population-based cohort in eastern europe. |
| PubMedID- 22347833 | Risk of lymphoma in patients with inflammatory bowel disease. |
| PubMedID- 23535248 | Risk factors for lymphoma in patients with inflammatory bowel disease: a case-control study. |
| PubMedID- 24395281 | We herein report a case of small intestinal malt lymphoma with protein-losing enteropathy (ple). |
| PubMedID- 22626508 | However, aza is associated with an increased risk of lymphoma in patients with inflammatory bowel disease. |
| PubMedID- 23390943 | Loss of response to biologics versus increased risk of lymphoma in children with inflammatory bowel disease: the clinician's conundrum. |
| PubMedID- 24574759 | Primary effusion lymphoma-like lymphoma in a patient with inflammatory bowel disease. |
| PubMedID- 24879926 | Risk of lymphoma in patients with inflammatory bowel disease treated with azathioprine and 6-mercaptopurine: a meta-analysis. |
| PubMedID- 20888436 | A systematic review of factors that contribute to hepatosplenic t-cell lymphoma in patients with inflammatory bowel disease. |
| PubMedID- 21887728 | Background: prior studies suggest an increased risk of lymphoma in adults with inflammatory bowel disease (ibd). |
Page: 1